1
|
Salgado RC, Gomes LN, França TT, da Silva Napoleão SM, Barreiros LA, de Oliveira TS, Ishizuka EK, Ferreira JFS, Condino-Neto A. Disseminated Histoplasmosis in a Brazilian Patient with G6PD Deficiency Caused by Class I Variant. J Clin Immunol 2023; 43:1796-1798. [PMID: 37814085 DOI: 10.1007/s10875-023-01599-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2023] [Accepted: 10/01/2023] [Indexed: 10/11/2023]
Affiliation(s)
- Ranieri Coelho Salgado
- Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, SP, Brazil.
| | - Lillian Nunes Gomes
- Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, SP, Brazil
| | - Tábata Takahashi França
- Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, SP, Brazil
| | | | - Lucila Akune Barreiros
- Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, SP, Brazil
| | - Tiago Santos de Oliveira
- Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, SP, Brazil
| | - Edson Kiyotaka Ishizuka
- Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, SP, Brazil
| | | | - Antonio Condino-Neto
- Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, SP, Brazil.
| |
Collapse
|
2
|
França TT, Barreiros LA, Salgado RC, da Silva Napoleão SM, Gomes LN, Ferreira JFS, Prando C, Weber CW, Di Gesu RSW, Montenegro C, Aranda CS, Kuntze G, Staines-Boone AT, Venegas-Montoya E, Becerra JCA, Bezrodnik L, Di Giovanni D, Moreira I, Seminario GA, Raccio ACG, de Barros Dorna M, Rosario-Filho NA, Chong-Neto HJ, de Carvalho E, Grotta MB, Orellana JC, Dominguez MG, Porras O, Sasia L, Salvucci K, Garip E, Leite LFB, Forte WCN, Pinto-Mariz F, Goudouris E, Nuñez MEN, Schelotto M, Ruiz LB, Liberatore DI, Ochs HD, Cabral-Marques O, Condino-Neto A. Correction to: CD40 Ligand Deficiency in Latin America: Clinical, Immunological, and Genetic Characteristics. J Clin Immunol 2022; 42:527-528. [PMID: 35129805 DOI: 10.1007/s10875-022-01221-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Affiliation(s)
- Tábata Takahashi França
- Department of Immunology, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, Brazil.
| | - Lucila Akune Barreiros
- Department of Immunology, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, Brazil
| | - Ranieri Coelho Salgado
- Department of Immunology, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, Brazil
| | | | - Lillian Nunes Gomes
- Department of Immunology, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, Brazil
| | | | - Carolina Prando
- Hospital Pequeno Principe, Curitiba, Brazil.,Faculdades Pequeno Principe, Curitiba, Brazil.,Instituto de Pesquisa Pele Pequeno Principe, Curitiba, Brazil
| | | | | | | | - Carolina Sanchez Aranda
- Servico de Alergia e Imunologia, Departamento de Pediatria, Universidade Federal de Sao Paulo, Sao Paulo, Brazil.,Jeffrey Modell Center Sao Paulo, Sao Paulo, Brazil
| | | | - Aidé Tamara Staines-Boone
- Immunology Service, Hospital de Especialidades Unidad Medica de Alta Especialidad (UMAE, Instituto Mexicano del Seguro Social (IMSS), Monterrey, Mexico
| | - Edna Venegas-Montoya
- Immunology Service, Hospital de Especialidades Unidad Medica de Alta Especialidad (UMAE, Instituto Mexicano del Seguro Social (IMSS), Monterrey, Mexico
| | | | - Liliana Bezrodnik
- Grupo de Imunologia, Hospital de Ninos Ricardo Gutierrez, Buenos Aires, Argentina
| | - Daniela Di Giovanni
- Grupo de Imunologia, Hospital de Ninos Ricardo Gutierrez, Buenos Aires, Argentina
| | - Ileana Moreira
- Grupo de Imunologia, Hospital de Ninos Ricardo Gutierrez, Buenos Aires, Argentina
| | | | | | - Mayra de Barros Dorna
- Divisao de Alergia e Imunologia, Departamento de Pediatria, Instituto da Crianca, Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil
| | | | | | - Elisa de Carvalho
- Gastroenterology and Hepatology Clinic, Brasilia Childrens Hospital, Brasilia, Brazil
| | | | - Julio Cesar Orellana
- Division Alergia e Imunologia Clinica, Hospital de Ninos de La Santisima Trinidad, Cordoba, Argentina
| | | | - Oscar Porras
- Hospital Nacional de Ninos Dr. Carlos Saenz Herrera, San Jose, Costa Rica
| | - Laura Sasia
- Hospital Infantil Municipal de Cordoba, Cordoba, Argentina
| | | | - Emilio Garip
- Hospital Infantil Municipal de Cordoba, Cordoba, Argentina
| | - Luiz Fernando Bacarini Leite
- Department of Pediatrics, Immunodeficiency Sector, Irmandade da Santa Casa de Misericordia de Sao Paulo, Sao Paulo, Brazil
| | | | - Fernanda Pinto-Mariz
- Department of Pediatrics, School of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
| | - Ekaterini Goudouris
- Department of Pediatrics, School of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
| | - María Enriqueta Nuñez Nuñez
- Department of Pediatrics, Division of Pediatric Allergy and Immunology, Hospital Civil de Guadalajara Dr. Juan I. Menchaca, Guadalajara, Mexico
| | | | - Laura Berrón Ruiz
- Unidad de Investigacion en Inmunodeficiencias, Instituto Nacional de Pediatria, Ciudad del Mexico, Mexico
| | | | - Hans D Ochs
- Department of Pediatrics, University of Washington School of Medicine, Seattle Children's Research Institute, Seattle, WA, USA
| | - Otavio Cabral-Marques
- Department of Immunology, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, Brazil.,Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of Sao Paulo, Sao Paulo, Brazil.,Network of Immunity in Infection, Malignancy, and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Sao Paulo, Brazil
| | - Antonio Condino-Neto
- Department of Immunology, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, Brazil. .,Jeffrey Modell Center Sao Paulo, Sao Paulo, Brazil.
| |
Collapse
|
3
|
França TT, Barreiros LA, Salgado RC, Napoleão SMDS, Gomes LN, Ferreira JFS, Prando C, Weber CW, Di Gesu RSW, Montenegro C, Aranda CS, Kuntze G, Staines-Boone AT, Venegas-Montoya E, Becerra JCA, Bezrodnik L, Di Giovanni D, Moreira I, Seminario GA, Raccio ACG, Dorna MDB, Rosário-Filho NA, Chong-Neto HJ, de Carvalho E, Grotta MB, Orellana JC, Dominguez MG, Porras O, Sasia L, Salvucci K, Garip E, Leite LFB, Forte WCN, Pinto-Mariz F, Goudouris E, Nuñez MEN, Schelotto M, Ruiz LB, Liberatore DI, Ochs HD, Cabral-Marques O, Condino-Neto A. CD40 Ligand Deficiency in Latin America: Clinical, Immunological, and Genetic Characteristics. J Clin Immunol 2022; 42:514-526. [PMID: 34982304 DOI: 10.1007/s10875-021-01182-5] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2021] [Accepted: 11/16/2021] [Indexed: 12/14/2022]
Abstract
CD40 ligand (CD40L) deficiency is a rare inborn error of immunity presenting with heterogeneous clinical manifestations. While a detailed characterization of patients affected by CD40L deficiency is essential to an accurate diagnosis and management, information about this disorder in Latin American patients is limited. We retrospectively analyzed data from 50 patients collected by the Latin American Society for Immunodeficiencies registry or provided by affiliated physicians to characterize the clinical, laboratory, and molecular features of Latin American patients with CD40L deficiency. The median age at disease onset and diagnosis was 7 months and 17 months, respectively, with a median diagnosis delay of 1 year. Forty-seven patients were genetically characterized revealing 6 novel mutations in the CD40LG gene. Pneumonia was the most common first symptom reported (66%). Initial immunoglobulin levels were variable among patients. Pneumonia (86%), upper respiratory tract infections (70%), neutropenia (70%), and gastrointestinal manifestations (60%) were the most prevalent clinical symptoms throughout life. Thirty-five infectious agents were reported, five of which were not previously described in CD40L deficient patients, representing the largest number of pathogens reported to date in a cohort of CD40L deficient patients. The characterization of the largest cohort of Latin American patients with CD40L deficiency adds novel insights to the recognition of this disorder, helping to fulfill unmet needs and gaps in the diagnosis and management of patients with CD40L deficiency.
Collapse
Affiliation(s)
- Tábata Takahashi França
- Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
| | - Lucila Akune Barreiros
- Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
| | - Ranieri Coelho Salgado
- Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
| | | | - Lillian Nunes Gomes
- Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
| | | | - Carolina Prando
- Hospital Pequeno Príncipe, Curitiba, Brazil.,Faculdades Pequeno Príncipe, Curitiba, Brazil.,Instituto de Pesquisa Pelé Pequeno Príncipe, Curitiba, Brazil
| | | | | | | | - Carolina Sanchez Aranda
- Serviço de Alergia e Imunologia, Departamento de Pediatria, Universidade Federal de São Paulo, São Paulo, Brazil.,Jeffrey Modell Center São Paulo, São Paulo, Brazil
| | | | - Aidé Tamara Staines-Boone
- Immunology Service, Hospital de Especialidades Unidad Médica de Alta Especialidad (UMAE, Instituto Mexicano del Seguro Social (IMSS), Monterrey, México
| | - Edna Venegas-Montoya
- Immunology Service, Hospital de Especialidades Unidad Médica de Alta Especialidad (UMAE, Instituto Mexicano del Seguro Social (IMSS), Monterrey, México
| | | | - Liliana Bezrodnik
- Grupo de Imunologia, Hospital de Niños Ricardo Gutierrez, Buenos Aires, Argentina
| | - Daniela Di Giovanni
- Grupo de Imunologia, Hospital de Niños Ricardo Gutierrez, Buenos Aires, Argentina
| | - Ileana Moreira
- Grupo de Imunologia, Hospital de Niños Ricardo Gutierrez, Buenos Aires, Argentina
| | | | | | - Mayra de Barros Dorna
- Divisão de Alergia e Imunologia, Departamento de Pediatria, Instituto da Criança, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
| | | | | | - Elisa de Carvalho
- Gastroenterology and Hepatology Clínic, Brasilia Childrens Hospital, Brasília, Brazil
| | | | - Julio Cesar Orellana
- Division Alergia e Imunologia Clinica, Hospital de Niños de La Santísima Trinidad, Córdoba, Argentina
| | | | - Oscar Porras
- Hospital Nacional de Niños Dr. Carlos Sáenz Herrera, San José, Costa Rica
| | - Laura Sasia
- Hospital Infantil Municipal de Córdoba, Córdoba, Argentina
| | | | - Emilio Garip
- Hospital Infantil Municipal de Córdoba, Córdoba, Argentina
| | - Luiz Fernando Bacarini Leite
- Department of Pediatrics, Immunodeficiency Sector, Irmandade da Santa Casa de Misericórdia de São Paulo, São Paulo, Brazil
| | | | - Fernanda Pinto-Mariz
- Department of Pediatrics, School of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
| | - Ekaterini Goudouris
- Department of Pediatrics, School of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
| | - María Enriqueta Nuñez Nuñez
- Department of Pediatrics, Division of Pediatric Allergy and Immunology, Hospital Civil de Guadalajara Dr. Juan I. Menchaca, Guadalajara, México
| | | | - Laura Berrón Ruiz
- Unidad de Investigación en Inmunodeficiencias, Instituto Nacional de Pediatría, Ciudad del México, México
| | | | - Hans D Ochs
- Department of Pediatrics, University of Washington School of Medicine, Seattle Children's Research Institute, Seattle, WA, USA
| | - Otavio Cabral-Marques
- Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.,Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.,Network of Immunity in Infection, Malignancy, and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), São Paulo, Brazil
| | - Antonio Condino-Neto
- Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil. .,Jeffrey Modell Center São Paulo, São Paulo, Brazil.
| |
Collapse
|
4
|
Martinez Viedma MDP, Panossian S, Gifford K, García K, Figueroa I, Parham L, de Moraes L, Nunes Gomes L, García-Salum T, Perret C, Weiskopf D, Tan GS, Augusto Silva A, Boaventura V, Ruiz-Palacios GM, Sette A, De Silva AD, Medina RA, Lorenzana I, Akrami KM, Khouri R, Olson D, Pickett BE. Evaluation of ELISA-Based Multiplex Peptides for the Detection of Human Serum Antibodies Induced by Zika Virus Infection across Various Countries. Viruses 2021; 13:1319. [PMID: 34372525 PMCID: PMC8310037 DOI: 10.3390/v13071319] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2021] [Revised: 06/18/2021] [Accepted: 07/06/2021] [Indexed: 01/02/2023] Open
Abstract
Zika virus (ZIKV) is a mosquito-borne Flavivirus with a positive-sense RNA genome, which are generally transmitted through the bite of an infected Aedes mosquito. ZIKV infections could be associated with neurological sequelae that, and otherwise produces similar clinical symptoms as other co-circulating pathogens. Past infection with one member of the Flavivirus genus often induces cross-reactive antibodies against other flaviruses. These attributes complicate the ability to differentially diagnose ZIKV infection from other endemic mosquito-borne viruses, making it both a public health issue as well as a diagnostic challenge. We report the results from serological analyses using arbovirus-specific peptides on 339 samples that were previously collected from 6 countries. Overall, we found that our multiplexed peptide-based ELISA was highly efficient for identifying ZIKV antibodies as early as 2 weeks post infection, and that it correlates with microneutralization, plaque reduction neutralization tests (PRNTs) and commercial tests for ZIKV in previously characterized samples. We observed that seropositivity varied by patient cohort, reflecting the sampling period in relation to the 2015-2016 ZIKV outbreak. This work evaluates the accuracy, specificity, and sensitivity of our peptide-based ELISA method for detecting ZIKV antibodies from geographically diverse regions. These findings can contribute to ongoing serological methods development and can be adapted for use in future studies.
Collapse
Affiliation(s)
| | | | - Kennedy Gifford
- Department of Microbiology and Molecular Biology, Brigham Young University, Provo, UT 84602, USA;
| | - Kimberly García
- Instituto de Investigacion en Microbiologia, Universidad Nacional Autónoma de Honduras, Tegucigalpa, Honduras; (K.G.); (I.F.); (L.P.); (I.L.)
| | - Isis Figueroa
- Instituto de Investigacion en Microbiologia, Universidad Nacional Autónoma de Honduras, Tegucigalpa, Honduras; (K.G.); (I.F.); (L.P.); (I.L.)
| | - Leda Parham
- Instituto de Investigacion en Microbiologia, Universidad Nacional Autónoma de Honduras, Tegucigalpa, Honduras; (K.G.); (I.F.); (L.P.); (I.L.)
| | - Laise de Moraes
- Institute Goncalo Moniz, Fiocruz Bahia, Salvador 40296-710, Brazil; (L.d.M.); (L.N.G.); (V.B.)
| | - Lillian Nunes Gomes
- Institute Goncalo Moniz, Fiocruz Bahia, Salvador 40296-710, Brazil; (L.d.M.); (L.N.G.); (V.B.)
| | - Tamara García-Salum
- Departmento de Enfermedades Infecciosas e Inmunología Pediátrica, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago H955+8Q, Chile; (T.G.-S.); (C.P.); (R.A.M.)
| | - Cecilia Perret
- Departmento de Enfermedades Infecciosas e Inmunología Pediátrica, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago H955+8Q, Chile; (T.G.-S.); (C.P.); (R.A.M.)
| | - Daniela Weiskopf
- Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA 92037, USA; (D.W.); (A.S.); (A.D.D.S.)
| | - Gene S. Tan
- J. Craig Venter Institute, La Jolla, CA 92137, USA; (M.d.P.M.V.); (G.S.T.)
- Department of Medicine, Infectious Diseases Division, University of California San Diego, La Jolla, CA 92037, USA
| | - Antônio Augusto Silva
- Hospital Universitário-Universidade Federal do Maranhão, São Luís 65000-000, Brazil;
| | - Viviane Boaventura
- Institute Goncalo Moniz, Fiocruz Bahia, Salvador 40296-710, Brazil; (L.d.M.); (L.N.G.); (V.B.)
- Faculdade de Medicina da Bahia-Universidade Federal da Bahia, Salvador 40000-000, Brazil; (K.M.A.); (R.K.)
| | | | - Alessandro Sette
- Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA 92037, USA; (D.W.); (A.S.); (A.D.D.S.)
- Department of Medicine, University of California San Diego, La Jolla, CA 92037, USA
| | - Aruna Dharshan De Silva
- Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA 92037, USA; (D.W.); (A.S.); (A.D.D.S.)
- Genetech Research Institute, Colombo 00800, Sri Lanka
- Department of Paraclinical Sciences, Faculty of Medicine, General Sir John Kotelawala Defence University, Ratmalana 10390, Sri Lanka
| | - Rafael A. Medina
- Departmento de Enfermedades Infecciosas e Inmunología Pediátrica, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago H955+8Q, Chile; (T.G.-S.); (C.P.); (R.A.M.)
- Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
| | - Ivette Lorenzana
- Instituto de Investigacion en Microbiologia, Universidad Nacional Autónoma de Honduras, Tegucigalpa, Honduras; (K.G.); (I.F.); (L.P.); (I.L.)
| | - Kevan M. Akrami
- Faculdade de Medicina da Bahia-Universidade Federal da Bahia, Salvador 40000-000, Brazil; (K.M.A.); (R.K.)
- Department of Medicine, University of California San Diego, La Jolla, CA 92037, USA
| | - Ricardo Khouri
- Faculdade de Medicina da Bahia-Universidade Federal da Bahia, Salvador 40000-000, Brazil; (K.M.A.); (R.K.)
| | - Daniel Olson
- Department of Pediatrics, Section of Infectious Diseases, University of Colorado School of Medicine, Aurora, CO 80045, USA;
| | - Brett E. Pickett
- J. Craig Venter Institute, La Jolla, CA 92137, USA; (M.d.P.M.V.); (G.S.T.)
- J. Craig Venter Institute, Rockville, MD 20850, USA;
- Department of Microbiology and Molecular Biology, Brigham Young University, Provo, UT 84602, USA;
| |
Collapse
|
5
|
Duarte AO, Oliveira JV, Carvalho TCX, Pessoa LDB, Filho CM, Lima JGS, Carvalho DA, Dos Santos DC, Santos CS, Pessoa R, Souza GB, Calcagno JI, Santana EM, de Oliveira AS, Francisco MVLDO, Costa BGG, Gomes LN, Romero F, Khouri R, Alcântara LC, Lima FWDM, de Siqueira IC. Maternal and congenital infections arising from Zika, dengue and Chikungunya arboviruses in Salvador, Brazil. Trans R Soc Trop Med Hyg 2021; 114:222-225. [PMID: 32142153 DOI: 10.1093/trstmh/trz098] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2019] [Revised: 07/30/2019] [Accepted: 07/31/2019] [Indexed: 11/14/2022] Open
Abstract
BACKGROUND Salvador was one of the Brazilian cities most affected during the 2015 Zika virus (ZIKV) outbreak. METHODS A cross-sectional study was performed with enrolment of parturients and their newborns. RESULTS Positive IgM antibodies for ZIKV, dengue (DENV) and Chikungunya (CHIKV) were present in 6.9, 11.9 and 22.8% of the parturients, and IgG antibodies were detected in 72.3, 92.3 and 38.6%, respectively. No cases of DENV congenital infection were identified. ZIKV and CHIKV congenital infections were observed in 16.5 and 13% of newborns, respectively. CONCLUSIONS High exposure rates to the three arboviruses and the identification of newborns with ZIKV and CHIKV congenital infections reinforces the necessity of ZIKV and CHIKV prenatal and neonatal screening in endemic regions.
Collapse
Affiliation(s)
- Alan Oliveira Duarte
- Laboratório de Imunologia de Doenças Infecciosas, Faculdade de Farmácia, Universidade Federal da Bahia, Salvador-BA, CEP 40170-115, Brazil
| | - João Vitor Oliveira
- Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Ministério da Saúde, Salvador-BA, CEP 40296-710, Brazil
| | | | - Lorena de Brito Pessoa
- Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Ministério da Saúde, Salvador-BA, CEP 40296-710, Brazil
| | - Cláudio Magalhães Filho
- Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Ministério da Saúde, Salvador-BA, CEP 40296-710, Brazil
| | | | - Daniel Augusto Carvalho
- Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Ministério da Saúde, Salvador-BA, CEP 40296-710, Brazil
| | - Daiana Carlos Dos Santos
- Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Ministério da Saúde, Salvador-BA, CEP 40296-710, Brazil
| | - Cleiton Silva Santos
- Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Ministério da Saúde, Salvador-BA, CEP 40296-710, Brazil
| | - Rosana Pessoa
- Maternidade de Referência Prof. José Maria de Magalhães Netto-SESAB, Salvador-BA, CEP 40320-350, Brazil
| | - Gloryane Bessa Souza
- Maternidade de Referência Prof. José Maria de Magalhães Netto-SESAB, Salvador-BA, CEP 40320-350, Brazil
| | - Juan Ignacio Calcagno
- Maternidade de Referência Prof. José Maria de Magalhães Netto-SESAB, Salvador-BA, CEP 40320-350, Brazil
| | - Edilene Mota Santana
- Laboratório de Imunologia de Doenças Infecciosas, Faculdade de Farmácia, Universidade Federal da Bahia, Salvador-BA, CEP 40170-115, Brazil
| | - Aline Sousa de Oliveira
- Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Ministério da Saúde, Salvador-BA, CEP 40296-710, Brazil
| | | | | | - Lillian Nunes Gomes
- Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Ministério da Saúde, Salvador-BA, CEP 40296-710, Brazil
| | - Fernando Romero
- Maternidade de Referência Prof. José Maria de Magalhães Netto-SESAB, Salvador-BA, CEP 40320-350, Brazil
| | - Ricardo Khouri
- Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Ministério da Saúde, Salvador-BA, CEP 40296-710, Brazil.,Departmento de Patologia e Medicina Legal, Faculdade de Medicina da Universidade Federal da Bahia, Salvador-BA, CEP 40110-100, Brazil
| | - Luiz Carlos Alcântara
- Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Ministério da Saúde, Salvador-BA, CEP 40296-710, Brazil
| | | | | |
Collapse
|
6
|
Takahasi EHM, Alves MTSSDB, Ribeiro MRC, Souza VFP, Simões VMF, Borges MCR, Amaral GA, Gomes LN, Khouri R, da Silva Sousa P, Silva AAMD. Gross Motor Function in Children with Congenital Zika Syndrome. Neuropediatrics 2021; 52:34-43. [PMID: 33111304 DOI: 10.1055/s-0040-1718919] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
BACKGROUND Little information on gross motor function of congenital Zika syndrome (CZS) children is available. OBJECTIVES To evaluate gross motor function in CZS children aged up to 3 years, and its associated factors and changes in a minimum interval of 6 months. METHODS One hundred children with CZS and cerebral palsy (36 with confirmed and 64 with presumed CZS) were evaluated with the Gross Motor Function Classification System (GMFCS) and Gross Motor Function Measure (GMFM-88/GMFM-66). Forty-six were reevaluated. Wilcoxon tests, Wilcoxon tests for paired samples, percentile scores, and score changes were performed. RESULTS Clinical and socioeconomic characteristics (except maternal age), GMFM scores and GMFCS classification of confirmed and probable cases, which were analyzed together, were similar. The mean age was 25.6 months (±5.5); the median GMFM-88 score was 8.0 (5.4-10.8); and the median GMFM-66 score was 20.5 (14.8-23.1); 89% were classified as GMFCS level V. Low economic class, microcephaly at birth, epilepsy, and brain parenchymal volume loss were associated with low GMFM-66 scores. The median GMFM-66 percentile score was 40 (20-55). On the second assessment, the GMFM-66 scores in two GMFCS level I children and one GMFCS level IV child improved significantly. In one GMFCS level III child, one GMFCS level IV child, and the group of GMFCS level V children, no significant changes were observed. CONCLUSIONS Almost all CZS children had severe cerebral palsy; in the third year of life, most presented no improvement in gross motor function and were likely approaching their maximal gross motor function potential.
Collapse
Affiliation(s)
- Eliana Harumi Morioka Takahasi
- Sarah Network of Neurorehabilitation Hospitals, São Luís, Maranhão, Brazil.,Public Health Department, Federal University of Maranhão, São Luís, Maranhão, Brazil
| | | | | | - Valéria Ferreira Pereira Souza
- Reference Center on Neurodevelopment, Assistance and Rehabilitation of Children - NINAR, State Department of Health of the State of Maranhão, São Luís, Maranhão, Brazil
| | | | | | | | - Lillian Nunes Gomes
- Laboratory of Immunology Human, Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, São Paulo, Brazil
| | - Ricardo Khouri
- Laboratory of Vector-Borne Infectious Diseases, Gonçalo Moniz Institute, Salvador, Bahia, Brazil.,Department of Pathology and Legal Medicine, Faculty of Medicine, Federal University of Bahia, Salvador, Bahia, Brazil
| | - Patricia da Silva Sousa
- Reference Center on Neurodevelopment, Assistance and Rehabilitation of Children - NINAR, State Department of Health of the State of Maranhão, São Luís, Maranhão, Brazil
| | | |
Collapse
|
7
|
Akrami KM, de Nogueira BMF, do Rosário MS, de Moraes L, Cordeiro MT, Haddad R, Gomes LN, de Pádua Carvalho I, dos Reis Pimentel E, de Jesus Silva J, de Oliveira Francisco MVL, de Siqueira IC, Farias D, Barral-Netto M, Barral A, Boaventura V, Khouri R. The re-emergence of Zika in Brazil in 2020: a case of Guillain Barré Syndrome during the low season for arboviral infections. J Travel Med 2020; 27:taaa165. [PMID: 32941627 PMCID: PMC7649381 DOI: 10.1093/jtm/taaa165] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/10/2020] [Revised: 08/20/2020] [Accepted: 08/27/2020] [Indexed: 12/25/2022]
Abstract
Zika virus cases in Brazil have diminished since emergence in 2015. We report Guillain Barré Syndrome caused by Zika and possible Chikungunya co-infection during an expected low arboviral season. This case highlights the importance of clinical vigilance for Zika in those with neurological syndromes outside typical arboviral season.
Collapse
Affiliation(s)
- Kevan M Akrami
- Instituto Gonçalo Moniz, FIOCRUZ, Salvador, Brazil
- Faculdade de Medicina da Bahia, Universidade Federal da Bahia, Salvador, Brazil
- Division of Infectious Diseases and Pulmonary Critical Care and Sleep Medicine, Department of Medicine, University of California, San Diego, CA, USA
| | - Betania Mara Freitas de Nogueira
- Instituto Gonçalo Moniz, FIOCRUZ, Salvador, Brazil
- Faculdade de Medicina da Bahia, Universidade Federal da Bahia, Salvador, Brazil
| | | | | | | | - Rodrigo Haddad
- Faculdade de Ceilândia, Universidade de Brasília, (FCE-UnB), Brasília, Brazil
| | | | | | | | | | | | | | | | | | | | - Viviane Boaventura
- Instituto Gonçalo Moniz, FIOCRUZ, Salvador, Brazil
- Faculdade de Medicina da Bahia, Universidade Federal da Bahia, Salvador, Brazil
| | - Ricardo Khouri
- Instituto Gonçalo Moniz, FIOCRUZ, Salvador, Brazil
- Faculdade de Medicina da Bahia, Universidade Federal da Bahia, Salvador, Brazil
| |
Collapse
|
8
|
Simoni RE, de Oliveira CP, Grassiano DM, dos Santos CM, Baruque MDG, Gomes LN, Machado CDS, Fernandes MJ, Braga MJ, de Albuquerque RM, de Oliveira ML. Screening for inborn errors of metabolism in high-risk children from Rio de Janeiro, Brazil. Early Hum Dev 1998; 50:305-11. [PMID: 9548034 DOI: 10.1016/s0378-3782(97)00111-4] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
From 1988 to 1995, our laboratory at the Institute of Chemistry of the Federal University of Rio de Janeiro, in Rio de Janeiro, screened 2650 samples from 2000 high-risk patients (mostly children) for Inborn Errors of Metabolism (IEM). Chemical tests, various chromatographic techniques and enzyme assays were performed on urine, plasma and in some cases, cerebrospinal fluid (CSF). A total of 145 cases of IEM (7.2%) was identified. These were related to: the metabolism of amino acids (41) and carbohydrates (17), organic acids (7), lysosomal enzymes (61), membrane transport system (16), metals (2), intestinal disaccharidases (1) and porphyrin metabolism (3). Furthermore, a relevant number of patients with abnormal findings is still under investigation. Biochemical results and clinical symptoms are presented and the importance of reference laboratories for the detection of IEM is stressed.
Collapse
Affiliation(s)
- R E Simoni
- Departament de Bioquímica, Instituto de Química, Universidade Federal do Rio de Janeiro, Brasil
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
9
|
Simoni RE, Gomes LN, Faria MS, Barbara Neto J, de Oliveira ML. Monitoring of a one-month ascorbic acid therapy in an alcaptonuric child; determinations by HPLC. J Inherit Metab Dis 1994; 17:632-3. [PMID: 7837775 DOI: 10.1007/bf00711607] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Affiliation(s)
- R E Simoni
- Department de Bioquímica, Universidade Federal do Rio de Janeiro, Brasil
| | | | | | | | | |
Collapse
|
10
|
Barreiro EJ, Costa PR, Gomes LN, Pereira AL. [Use of natural sources in the preparation of biologically active compounds. I: Prostanoids]. AN ACAD BRAS CIENC 1981; 53:61-3. [PMID: 7197135] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/24/2023] Open
Abstract
In order to improve the knowledge on the natural sources of Brazilian florae, a research program is in course for the preparation of different groups of compounds which could have biological activity, using abundant Natural Products as starting materials. This paper deals with the work and results in the formal synthesis of prostaglandin analogs.
Collapse
|